Study highlights potential of p-tau217 assays in Alzheimer’s clinical trials and diagnosis Post author: Post published:March 14, 2024 Post category:uncategorized The performance of two commercial phospho-tau217 (p-tau217) assays. You Might Also Like Innovative modeling framework to reconstruct data on fertility and education December 5, 2023 Can catching some rays help you fight off type 2 diabetes? October 1, 2023 Scientists develop gene therapy approach for rare paralyzing disease October 22, 2023